All Products
Also known as
LUTS, Lower Urinary Tract Dysfunction, Prostatism (outdated term for men), Storage and Voiding Problems, Bladder Outlet Obstruction Symptoms, Urinary Dysfunction
Definition
Lower urinary tract symptoms (LUTS) refer to a group of clinical symptoms involving the bladder, urinary sphincter, urethra and, in men, the prostate.¹ LUTS encompasses both storage (irritative) and voiding (obstructive) symptoms that affect the lower urinary tract.² Storage symptoms include increased frequency of urination, increased urgency, urge incontinence, and nocturia, while voiding symptoms include poor stream, hesitancy, terminal dribbling, incomplete voiding, and urinary retention.³ These symptoms are common among aging men and women, though more prevalent in men, and can significantly impact quality of life.⁴ LUTS may be caused by various conditions including benign prostatic hyperplasia (BPH), bladder dysfunction, urinary tract infections, neurological disorders, or other pathologies affecting the lower urinary tract.⁵
Clinical Context
LUTS are commonly encountered in clinical practice, particularly in aging populations. The prevalence increases with age, affecting approximately 8% of men aged 31-40 years, 50% in those aged 51-60 years, 70% in those aged 61-70 years, and 90% in those aged 81-90 years.¹
Patient evaluation typically includes a thorough history, physical examination, urinalysis, assessment using validated questionnaires such as the International Prostate Symptom Score (IPSS), measurement of post-void residual volume, and urinary flow studies.² Additional diagnostic tests may include pressure/flow studies, urodynamics, renal ultrasound, and cystoscopy in selected cases.³
Treatment options vary based on symptom severity, underlying causes, and patient preferences. First-line management often includes lifestyle modifications such as fluid management and timed voiding. Pharmacological treatments include:
- Alpha-adrenergic receptor blockers (alfuzosin, doxazosin, tamsulosin, terazosin) – provide quick symptomatic relief by relaxing smooth muscle in the prostate and bladder neck.⁴
- 5-alpha-reductase inhibitors (finasteride, dutasteride) – reduce prostate size by inhibiting conversion of testosterone to dihydrotestosterone, more effective in men with larger prostates.⁵
- Antimuscarinic agents (tolterodine, oxybutynin) – helpful for storage symptoms, particularly when combined with alpha blockers in patients with mixed symptoms.⁶
- Phosphodiesterase type 5 (PDE-5) inhibitors – beneficial for patients with both LUTS and erectile dysfunction.⁷
- Combination therapies – alpha blockers with 5-alpha-reductase inhibitors for men at risk of disease progression; alpha blockers with antimuscarinic agents for mixed storage and voiding symptoms.⁸
Surgical interventions are considered when medical therapy fails or is contraindicated, including transurethral resection of the prostate (TURP), laser procedures, minimally invasive surgical treatments, and in severe cases, artificial urinary sphincter placement for incontinence.⁹